- Corporate Officers - L
- Lubner David Charles
Insider Trading History of Lubner David Charles
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lubner David Charles since 2015.
This trader's CIK number is 1572000.
At the time of last reporting, Lubner David Charles was the Officer of Arcellx, Inc.. (stock ticker symbol ACLX).
Also see all insider trading activities at Arcellx, Inc..
Note that in the past
Lubner David Charles also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Ra Pharmaceuticals, Inc. (RARX) by Lubner David Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | RARX | 0 | $0 | 0 | $0 | 10,417 | $0 |
Yearly summary of insider trading at Point Biopharma Global Inc. (PNT) by Lubner David Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | PNT | 3,600 | $24,660 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tetraphase Pharmaceuticals Inc (TTPH) by Lubner David Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | TTPH | 0 | $0 | 49,500 | $2,089,265 | 39,500 | $158,490 |
Yearly summary of insider trading at Arcellx, Inc. (ACLX) by Lubner David Charles
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | ACLX | 0 | $0 | 6,000 | $450,000 | 6,000 | $37,680 |
Insider trading activities at 4 companies by Lubner David Charles:
1. Ra Pharmaceuticals, Inc. (RARX)
2. Point Biopharma Global Inc. (PNT)
3. Tetraphase Pharmaceuticals Inc (TTPH)
4. Arcellx, Inc. (ACLX)
Table 1. Insider trading of Ra Pharmaceuticals, Inc. (RARX) by Lubner David Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-02-01 | RARX | Option Ex | 10,417 | .00 | 0 |
Table 2. Insider trading of Point Biopharma Global Inc. (PNT) by Lubner David Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-11-23 | PNT | Buy | 3,600 | 6.85 | 24,660 |
Table 3. Insider trading of Tetraphase Pharmaceuticals Inc (TTPH) by Lubner David Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-08-14 | TTPH | Option Ex | 9,500 | 7.94 | 75,430 |
| 2015-08-14 | TTPH | Sale | 9,500 | 42.92 | 407,740 |
| 2015-07-14 | TTPH | Option Ex | 7,500 | 4.99 | 37,387 |
| 2015-07-14 | TTPH | Sale | 7,500 | 48.92 | 366,900 |
| 2015-06-15 | TTPH | Option Ex | 7,500 | 2.03 | 15,224 |
| 2015-06-15 | TTPH | Sale | 7,500 | 41.67 | 312,525 |
| 2015-06-12 | TTPH | Sale | 10,000 | 41.29 | 412,900 |
| 2015-05-14 | TTPH | Option Ex | 15,000 | 2.03 | 30,449 |
| 2015-05-14 | TTPH | Sale | 15,000 | 39.28 | 589,200 |
Table 4. Insider trading of Arcellx, Inc. (ACLX) by Lubner David Charles
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-01-20 | ACLX | Option Ex | 6,000 | 6.28 | 37,680 |
| 2026-01-20 | ACLX | Sale | 6,000 | 75.00 | 450,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Lubner David Charles
(Officer of Arcellx, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.